Using a Dopamine Type IA Receptor Agonist in High-Risk Patients to Ameliorate Contrast-Associated Nephropathy

Using a Dopamine Type IA Receptor Agonist in High-Risk Patients to Ameliorate Contrast-Associated Nephropathy

Saved in:
Bibliographic Details
Published in:American journal of roentgenology (1976) Vol. 179; no. 3; pp. 591 - 596
Main Authors: Chamsuddin, Abbas A, Kowalik, Karen J, Bjarnason, Haraldur, Dietz, Charles A, Rosenberg, Michael S, Gomes, Maria D, McDermott, Colleen M, Hunter, David W
Format: Journal Article
Language:English
Published: Leesburg, VA Am Roentgen Ray Soc 01-09-2002
American Roentgen Ray Society
Subjects:
Biological and medical sciences
Drug toxicity and drugs side effects treatment
Medical sciences
Pharmacology. Drug treatments
Toxicity: urogenital system
Urinary system
Kidney disease
Human
High risk
Agonist
Urinary system disease
Renal function
Radiodiagnosis
Toxicity
D1 Dopamine receptor
Fenoldopam
Prevention
Chemotherapy
Nephropathy
Influence
Therapeutic protocol
Contrast media
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0361-803X
1546-3141
DOI:10.2214/ajr.179.3.1790591